Lv4
660 积分 2025-10-02 加入
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
19天前
已完结
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study
1个月前
已完结
Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648
1个月前
已完结
No evidence for depletion of circulating lymphocyte populations in primary brain tumor patients receiving radiotherapy alone
3个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
3个月前
已完结
No evidence for depletion of circulating lymphocyte populations in primary brain tumor patients receiving radiotherapy alone
3个月前
已完结
No evidence for depletion of circulating lymphocyte populations in primary brain tumor patients receiving radiotherapy alone
3个月前
已关闭
Proton Therapy May Reduce the Risk of Cancer Progression During Immune Checkpoint Inhibitor Therapy: A Propensity Score-Matched Analysis of Intensity Modulated Proton Versus Photon Radiation Therapy
3个月前
已完结
Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
皖公网安备34019202002308
